Single-cell transcriptomic reveals molecular diversity and developmental heterogeneity of human stem cell-derived oligodendrocyte lineage cells

Xitiz Chamling, Alyssa Kallman, Weixiang Fang, Cynthia Berlinicke, Joseph Mertz, Prajwal Devkota, Itzy E. Morales Pantoja, Matthew D. Smith, Zhicheng Ji, Calvin Chang, Aniruddha M. Kaushik, Liben Chen, Katharine A. Whartenby, Peter A. Calabresi, Hai‐Quan Mao, Hongkai Ji, Tza‐Huei Wang, Donald J. ZackNature Communications 2021 · DOI

TL;DR

This study uses single-cell transcriptomics to map the developmental pathways of human oligodendrocyte lineage cells derived from stem cells. By creating a novel reporter system and analyzing cells over time, researchers uncovered significant molecular diversity within oligodendrocyte progenitor cells (OPCs) and identified key regulatory pathways involved in their maturation into oligodendrocytes and astrocytes. This work provides a crucial foundation for developing new treatments for demyelinating diseases like multiple sclerosis.

What Problem Does This Paper Address?

Demyelinating diseases, such as multiple sclerosis (MS), arise from damage to oligodendrocytes, the cells responsible for myelinating neurons in the central nervous system. While current treatments can manage symptoms, there's a critical need for therapies that promote remyelination. To achieve this, a deeper understanding of how human oligodendrocytes develop is essential. Previous research has largely relied on rodent models, but fundamental differences exist between rodent and human oligodendrocyte progenitor cells (OPCs). Therefore, detailed transcriptomic analysis of human stem cell-derived oligodendrocyte lineage cells (hOLLCs) is crucial for advancing remyelination strategies. A key challenge in this area has been the difficulty in obtaining sufficient numbers of pure, well-characterized hOLLCs for study.

Methods

The researchers developed a novel human embryonic stem cell (hESC) reporter line by engineering an "Identification-and-Purification" (IAP) tag into the endogenous PDGFRα locus. This tag, consisting of tdTomato (a fluorescent marker) and Thy1.2 (a cell surface protein), allows for the scalable differentiation and purification of PDGFRα-expressing hOLLCs. They then employed droplet-based single-cell RNA sequencing (Drop-seq) on these reporter cells at multiple time points during differentiation. To further validate their findings, they also analyzed cells derived from an unmodified induced pluripotent stem (iPS) cell line. Pseudotime trajectory analysis was used to model developmental pathways, and pathway enrichment analysis (using Ingenuity Pathway Analysis - IPA) identified key molecular pathways. Pharmacological interventions were used to test the functional relevance of identified pathways.

Datasets

The study utilized single-cell RNA sequencing data from:

  • Human embryonic stem cell (hESC)-derived oligodendrocyte lineage cells (hOLLCs) generated using their novel PDGFRα-tdTomato-Thy1.2 reporter line at three different time points (days 77, 89, and 104).
  • hOLLCs derived from an unmodified induced pluripotent stem (iPS) cell line.
  • Publicly available single-nucleus RNA-seq (snRNA-seq) datasets from adult and fetal human brains for reference and label transfer.

No new benchmarks were introduced; rather, existing datasets were integrated for comparative analysis.

Key Insights and Ideas

  • A Novel Reporter System for Scalable OPC Purification: The development of the PDGFRα-tdTomato-Thy1.2 reporter hESC line is a significant technical advancement, enabling efficient and scalable purification of PDGFRα+ hOLLCs, which has been a bottleneck in the field.
  • Unveiling OPC Heterogeneity: The single-cell analysis revealed substantial transcriptional heterogeneity within human OPC populations, suggesting distinct sub-populations with unique developmental trajectories and potential functions.
  • Identification of a Cytokine-Responsive OPC Subset: The study identified a specific sub-population of OPCs that are enriched for genes involved in cytokine-mediated signaling and immune response, suggesting a role in responding to inflammatory cues.
  • Defining Developmental Trajectories: Pseudotime analysis provided a clear picture of the developmental pathways from PDGFRα-expressing OPCs towards both oligodendrocytes and astrocytes, highlighting the bipotential nature of these precursor cells.
  • Species-Specific Transcriptomic Differences: The study confirmed and expanded upon known differences between human and mouse OPC transcriptomes, identifying specific genes enriched in human OLs and astrocytes that are not found in their mouse counterparts.
  • Pharmacological Validation of Key Pathways: The experimental validation of the roles of mTOR and cholesterol biosynthesis pathways in oligodendrocyte maturation provides concrete targets for future therapeutic development.

Key Results

  • The reporter system allowed for the purification of >90% pure PDGFRα/tdTomato-expressing hOLLCs.
  • Single-cell transcriptomic analysis of over 3200 cells identified 13 distinct cell populations, including several OPC sub-clusters, oligodendrocyte clusters, and astrocyte clusters.
  • Pseudotime analysis revealed two main developmental paths from PDGFRα+ precursors, leading to oligodendrocyte and astrocyte lineages.
  • Pathway enrichment analysis identified cholesterol biosynthesis and mTOR signaling as critical for oligodendrocyte maturation. Pharmacological inhibition of cholesterol biosynthesis enzymes increased MBP expression, a marker of mature oligodendrocytes.
  • Inhibition of mTOR signaling reduced MBP expression and increased OPC markers, indicating its essential role in maturation.

Limitations and Future Work

  • In Vitro vs. In Vivo: The study acknowledges that findings are based on in vitro differentiation and that further validation in vivo is necessary to confirm the observed lineage specification and developmental roles of identified transcription factors.
  • PDGFRα Expression in Mature Cells: The detection of PDGFRα protein in purified mature OLs and astrocytes, despite low mRNA levels, suggests potential post-transcriptional regulation or longer protein half-lives, which warrants further investigation.
  • Species-Specific Differences: While highlighting human-specific genes, the study notes that a comprehensive understanding of species-specific differences requires further detailed comparative analysis.
  • Future Directions: The authors suggest that their reporter system and scRNA-seq data will be valuable for future studies to elucidate the molecular mechanisms of human OL differentiation, maturation, and myelination. They also propose exploring the identified transcription factors for their roles in lineage specification and investigating the potential for SARS-CoV-2 to infect CNS progenitor cells. Further research into the identified pathways could lead to new drug discovery efforts for remyelination therapies.

Summary updated

Abstract

Injury and loss of oligodendrocytes can cause demyelinating diseases such as multiple sclerosis. To improve our understanding of human oligodendrocyte development, which could facilitate development of remyelination-based treatment strategies, here we describe time-course single-cell-transcriptomic analysis of developing human stem cell-derived oligodendrocyte-lineage-cells (hOLLCs). The study includes hOLLCs derived from both genome engineered embryonic stem cell (ESC) reporter cells containing an Identification-and-Purification tag driven by the endogenous PDGFRα promoter and from unmodified induced pluripotent (iPS) cells. Our analysis uncovers substantial transcriptional heterogeneity of PDGFRα-lineage hOLLCs. We discover sub-populations of human oligodendrocyte progenitor cells (hOPCs) including a potential cytokine-responsive hOPC subset, and identify candidate regulatory genes/networks that define the identity of these sub-populations. Pseudotime trajectory analysis defines developmental pathways of oligodendrocytes vs astrocytes from PDGFRα-expressing hOPCs and predicts differentially expressed genes between the two lineages. In addition, pathway enrichment analysis followed by pharmacological intervention of these pathways confirm that mTOR and cholesterol biosynthesis signaling pathways are involved in maturation of oligodendrocytes from hOPCs.
BibTeX
@inproceedings{chamling2021single,
  author = {Xitiz Chamling and Alyssa Kallman and Weixiang Fang and Cynthia Berlinicke and Joseph Mertz and Prajwal Devkota and Itzy E. Morales Pantoja and Matthew D. Smith and Zhicheng Ji and Calvin Chang and Aniruddha M. Kaushik and Liben Chen and Katharine A. Whartenby and Peter A. Calabresi and Hai‐Quan Mao and Hongkai Ji and Tza‐Huei Wang and Donald J. Zack},
  title = {{Single-cell transcriptomic reveals molecular diversity and developmental heterogeneity of human stem cell-derived oligodendrocyte lineage cells}},
  booktitle = {Nature Communications},
  year = {2021},
  doi = {10.1038/s41467-021-20892-3},
}
Figure